Changes in body composition during adjuvant chemotherapy for breast cancer.
Aslani
A
A
Department of Nuclear Medicine, Royal North Shore Hospital, St Leonards, NSW, Australia.
Smith
R C
RC
Allen
B J
BJ
Levi
J A
JA
D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D000886:Anthropometry / Q000379:methods; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001823:Body Composition / Q000187:drug effects / Q000502:physiology*; D001835:Body Weight; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000503:physiopathology* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D003520:Cyclophosphamide; D005260:Female; D005472:Fluorouracil; D006801:Humans; D008727:Methotrexate; D008875:Middle Aged; D009584:Nitrogen / Q000032:analysis; D011506:Proteins / Q000032:analysis
D011506:Proteins; D003520:Cyclophosphamide; D009584:Nitrogen; D005472:Fluorouracil; D008727:Methotrexate